Potential Hepatitis C Breakthrough for Santaris
In preliminary testing done on chimpanzees chronically infected with the hepatitis C virus, SPC3649 dramatically reduced virus levels with no toxic side effects.
monogram biosciences
Potential Breakthrough in Search for AIDS Vaccine
Scientists at the Scripps Research Institute have isolated two antibodies that can prevent patients with HIV from developing severe AIDS.
Anadys Shares Jump Following Hepatitis C Drug Trial
Shares in Anadys Pharmaceuticals rose 28 percent following the announcement of promising results in a clinical trial of its experimental hepatitis C drug ANA773.
Special Report: Fighting the U.S. AIDS Epidemic
An estimated 1.2 million people in the U.S. have the HIV virus. OneMedPlace speaks with AIDS advocate Michael Manganiello about the scope of the epidemic, the possibility of a vaccine, and what needs to happen to make a national AIDS strategy a reality.